Referral pattern for neoadjuvant chemotherapy in the head and neck cancers in a tertiary care center.

Patil, V M; Noronha, V; Joshi, A; Krishna, V M; Dhumal, S; Chaudhary, V; Juvekar, S; Pai, P S; Pankaj, C; Chaukar, D; Dcruz, A K; Prabhash, K.
Indian J Cancer ; 2014 Apr-Jun; 51(2): 100-103
Artículo en Inglés | IMSEAR | ID: sea-154303

Documentos relacionados

  1. Factors associated with masticatory function as measured with the Mixing Ability Test in patients with head and neck cancer before and after treatment: a prospective cohort study.
  2. Current radiotherapy for recurrent head and neck cancer in the modern era: a state-of-the-art review.
  3. Methodological Issues with Head and Neck Cancer Prognostic Risk Prediction Models.
  4. Dual checkpoint T(h1)eamwork makes the anti-cancer dream work.
  5. Immune checkpoint blockade provokes resident memory T cells to eliminate head and neck cancer.
  6. A genome-wide association study of radiotherapy induced toxicity in head and neck cancer patients identifies a susceptibility locus associated with mucositis.
  7. Subsite-specific trends in mid- and long-term survival for head and neck cancer patients in Japan: A population-based study.
  8. Head and neck cancer patient-derived tumouroid cultures: opportunities and challenges.
  9. Chronic heart failure in patients undergoing major head and neck surgery: A hospital-based study.
  10. DNA Damage Response Mechanisms in Head and Neck Cancer: Significant Implications for Therapy and Survival.